search
Back to results

Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults

Primary Purpose

Bardet-Biedl Syndrome, Orphan Diseases

Status
Completed
Phase
Locations
France
Study Type
Observational
Intervention
clinical, biological, and radiological
Sponsored by
University Hospital, Strasbourg, France
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Bardet-Biedl Syndrome focused on measuring Bardet-Biedl syndrome, retinitis pigmentosa, obesity, genes

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All Sexes

Inclusion Criteria: Adult (age over 16 years old) At least 3 of the five major criteria (retinitis pigmentosa, obesity, polydactyly, cognitive impairment, and kidney disorder) and/or BBS mutations identified

Sites / Locations

  • Hélène Dollfus

Outcomes

Primary Outcome Measures

Outcome evaluated end 2005 and 2006
Clinical results (natural history, phenotype-genotype correlations, genetic epidemiology, new genes identification

Secondary Outcome Measures

This study may lead to further clinical investigations according to the results (new protocol to be established) and to further molecular investigations

Full Information

First Posted
September 13, 2005
Last Updated
August 7, 2008
Sponsor
University Hospital, Strasbourg, France
search

1. Study Identification

Unique Protocol Identification Number
NCT00213811
Brief Title
Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults
Official Title
Bardet-Biedl Syndrome: Clinical and Genetic Epidemiology Study in the Adults
Study Type
Observational

2. Study Status

Record Verification Date
August 2008
Overall Recruitment Status
Completed
Study Start Date
June 2003 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
University Hospital, Strasbourg, France

4. Oversight

5. Study Description

Brief Summary
This study is based on the study of the natural history of a rare disorder: the Bardet-Biedl syndrome (BBS) (which is associated with retinitis pigmentosa, polydactyly, cognitive impairment, obesity, and kidney failure). The clinical, biological, and radiological features of adult patients are studied. In parallel, a molecular study is performed on the known genes to date (8 genes from BBS1 to BBS8) and to identify new genes involved. The parts of the study are combined in a phenotype-genotype correlation study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bardet-Biedl Syndrome, Orphan Diseases
Keywords
Bardet-Biedl syndrome, retinitis pigmentosa, obesity, genes

7. Study Design

Enrollment
40 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
clinical, biological, and radiological
Primary Outcome Measure Information:
Title
Outcome evaluated end 2005 and 2006
Title
Clinical results (natural history, phenotype-genotype correlations, genetic epidemiology, new genes identification
Secondary Outcome Measure Information:
Title
This study may lead to further clinical investigations according to the results (new protocol to be established) and to further molecular investigations

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Eligibility Criteria
Inclusion Criteria: Adult (age over 16 years old) At least 3 of the five major criteria (retinitis pigmentosa, obesity, polydactyly, cognitive impairment, and kidney disorder) and/or BBS mutations identified
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hélène Dollfus, MD
Organizational Affiliation
Fédération Génétique
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
J-Louis Mandel, MD
Organizational Affiliation
IGBMC
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Pascal Bousquet, MD
Organizational Affiliation
CIC Strasbourg
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Christian Brandt, MD
Organizational Affiliation
CIC Strasbourg
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Catherine Arnold, MD
Organizational Affiliation
CIC Strasbourg
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Alain Verloes, MD
Organizational Affiliation
Unité de Génétique Robert Debré
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Régis Hanfard, MD
Organizational Affiliation
CIC Robet Debré
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Didier Lacombe, MD
Organizational Affiliation
Service de Génétique Médicale/Bordeaux
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Virginie Bernard, MD
Organizational Affiliation
CIC Bordeaux
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sylvie Manouvrier, MD
Organizational Affiliation
Service de Génétique Médicale Lille
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hélène Dollfus
City
Strasbourg
Country
France

12. IPD Sharing Statement

Learn more about this trial

Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults

We'll reach out to this number within 24 hrs